It is a peptide drug for the treatment of type 2 diabetes and obesity. The prevalence of obesity and diabetes is a global problem. Tirzepatide is a
Topiramate. Topiramate is an antiepileptic drug. It has not been approved by the Therapeutic Goods Administration for the treatment of obesity in Australia because no one has applied to register it for treating obesity. However, topiramate in combination with phentermine was approved for the treatment of obesity by the FDA in 2024.
This would be the most highly efficacious drug ever approved for the treatment of obesity, said Dr. Fatima Cody Stanford, an obesity medicine
The answer is yes, it can. It is off label for obesity treatment, but it can be used for obesity treatment.
new drug candidates for the treatment of type 2 diabetes and obesity. Combination of drugs for obesity and type 2 diabetes may be more
In this piece, we discuss Medicare coverage of obesity treatments, the potential cost implications if Medicare covers anti-obesity drugs
Weight loss drugs are designed to help people who are classified as obese lose weight. The main aims in the treatment of obesity are to lose
CMS characterizes obesity predominantly in terms of an individual's weight and maintains that drugs for obesity treatment are not covered by
A new update of STAT's Obesity Drug Tracker shows that at about one-fifth of the 105 obesity treatments in development or on the market are
Comments